Nathan Treybeck
Stock Analyst at Wells Fargo
(1.67)
# 3,390
Out of 5,127 analysts
23
Total ratings
33.33%
Success rate
3.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Equal-Weight | $265 → $270 | $263.54 | +2.45% | 2 | Jan 30, 2026 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $220 → $225 | $152.22 | +47.81% | 6 | Jan 13, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $97 → $93 | $87.98 | +5.71% | 2 | Nov 7, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $58 → $51 | $29.95 | +70.28% | 9 | Nov 5, 2025 | |
| ITGR Integer Holdings | Downgrades: Equal-Weight | $132 → $80 | $86.15 | -7.14% | 4 | Oct 24, 2025 |
ResMed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $265 → $270
Current: $263.54
Upside: +2.45%
iRhythm Holdings
Jan 13, 2026
Maintains: Overweight
Price Target: $220 → $225
Current: $152.22
Upside: +47.81%
LeMaitre Vascular
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $97 → $93
Current: $87.98
Upside: +5.71%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Overweight
Price Target: $58 → $51
Current: $29.95
Upside: +70.28%
Integer Holdings
Oct 24, 2025
Downgrades: Equal-Weight
Price Target: $132 → $80
Current: $86.15
Upside: -7.14%